Home In vitro thrombogenicity evaluation of rotary blood pumps by thromboelastometry
Article
Licensed
Unlicensed Requires Authentication

In vitro thrombogenicity evaluation of rotary blood pumps by thromboelastometry

  • Mario Klein ORCID logo , Jana Christine Tack , Ilona Mager , Judith Maas , Thomas Schmitz-Rode , Jutta Arens ORCID logo , Ulrich Steinseifer and Johanna Charlotte Clauser ORCID logo EMAIL logo
Published/Copyright: August 31, 2022

Abstract

In vitro thrombogenicity tests for rotary blood pumps (RBPs) could benefit from assessing coagulation kinematics, as RBP design improves. In this feasibility study, we investigated if the method of thromboelastometry (TEM) is able to assess coagulation kinematics under the in vitro conditions of RBP tests. We conducted in vitro thrombogenicity tests (n=4) by placing Deltastream® DP3 pumps into test loops that were filled with 150 mL of slightly anti-coagulated porcine blood, adjusted to an activated clotting time (ACT) well below clinically recommended levels. Blood samples were taken at certain time points during the experiment until a continuous decrease in pump flow indicated major thrombus formation. Blood samples were analyzed for ACT, platelet count (PLT), and several TEM parameters. While visible thrombus formation was observed in three pumps, ACT indicated an ongoing activation of coagulation, PLT might have indicated platelet consumption. Unexpectedly, most TEM results gave no clear indications. Nonetheless, TEM clotting time obtained by non-anticoagulated and chemically non-activated whole blood (HEPNATEM-CT) appeared to be more sensitive for the activation of coagulation in vitro than ACT, which might be of interest for future pump tests. However, more research regarding standardization of thrombogenicity pump tests is urgently required.


Corresponding author: Johanna Charlotte Clauser, Department of Cardiovascular Engineering, Institute of Applied Medical Engineering, Helmholtz Institute, Medical Faculty, RWTH Aachen University, University Hospital Aachen, Pauwelsstr. 20, 52074 Aachen, Germany, Fax: +49 241 80-82442, E-mail:

Funding source: European Regional Development Fund http://dx.doi.org/10.13039/501100008530

Award Identifier / Grant number: EFRE-0800410

Acknowledgments

The authors thank Yasmin Kuhn, Gereon Fischer and Andrea Sieg (Institute of Applied Medical Engineering) for their assistance during the thrombogenicity tests.

  1. Research funding: The authors acknowledge funding provided by the federal state of North Rhine-Westphalia and the European Regional Development Fund (ERDF), Grant number: EFRE-0800410, https://doi.org/10.13039/501100008530. The funding organizations played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Not applicable.

  5. Ethical approval: Not applicable.

References

1. Kirklin, JK, Pagani, FD, Kormos, RL, Stevenson, LW, Blume, ED, Myers, SL, et al.. Eighth annual INTERMACS report: special focus on framing the impact of adverse events. J Heart Lung Transplant 2017;36:1080–6. https://doi.org/10.1016/j.healun.2017.07.005.Search in Google Scholar PubMed

2. Murphy, DA, Hockings, LE, Andrews, RK, Aubron, C, Gardiner, EE, Pellegrino, VA, et al.. Extracorporeal membrane oxygenation-hemostatic complications. Transfus Med Rev 2015;29:90–101. https://doi.org/10.1016/j.tmrv.2014.12.001.Search in Google Scholar PubMed

3. Wu, W-T, Yang, F, Wu, J, Aubry, N, Massoudi, M, Antaki, JF. High fidelity computational simulation of thrombus formation in Thoratec HeartMate II continuous flow ventricular assist device. Sci Rep 2016;6:38025. https://doi.org/10.1038/srep38025.Search in Google Scholar PubMed PubMed Central

4. Selmi, M, Chiu, W-C, Chivukula, VK, Melisurgo, G, Beckman, JA, Mahr, C, et al.. Blood damage in left ventricular assist devices: pump thrombosis or system thrombosis? Int J Artif Organs 2019;42:113–24. https://doi.org/10.1177/0391398818806162.Search in Google Scholar PubMed

5. Maruyama, O, Tomari, Y, Sugiyama, D, Nishida, M, Tsutsui, T, Yamane, T. Simple in vitro testing method for antithrombogenic evaluation of centrifugal blood pumps. Am Soc Artif Intern Organs J 2009;55:314–22. https://doi.org/10.1097/mat.0b013e3181a7b540.Search in Google Scholar PubMed

6. Schima, H, Siegl, H, Mohammad, SF, Huber, L, Müller, MR, Losert, U, et al.. In vitro investigation of thrombogenesis in rotary blood pumps. Artif Organs 1993;17:605–8. https://doi.org/10.1111/j.1525-1594.1993.tb00602.x.Search in Google Scholar PubMed

7. Tayama, E, Ohtsubo, S, Nakazawa, T, Takami, Y, Niimi, Y, Makinouchi, K, et al.. In vitro thrombogenic evaluation of centrifugal pumps. Artif Organs 1997;21:418–20. https://doi.org/10.1111/j.1525-1594.1997.tb03727.x.Search in Google Scholar PubMed

8. Tayama, E, Ohtsubo, S, Nakazawa, T, Takami, Y, Niimi, Y, Makinouchi, K, et al.. The simple in vitro thrombogenic test: modified methods for same priming pumps. Artif Organs 1997;21:1305–8. https://doi.org/10.1111/j.1525-1594.1997.tb00495.x.Search in Google Scholar PubMed

9. Paul, R, Marseille, O, Hintze, E, Huber, L, Schima, H, Reul, H, et al.. In vitro thrombogenicity testing of artificial organs. Int J Artif Organs 1998;21:548–52. https://doi.org/10.1177/039139889802100910.Search in Google Scholar

10. Hastings, SM, Deshpande, SR, Wagoner, S, Maher, K, Ku, DN. Thrombosis in centrifugal pumps: location and composition in clinical and in vitro circuits. Int J Artif Organs 2016;39:200–4. https://doi.org/10.5301/ijao.5000498.Search in Google Scholar PubMed

11. Mehra, MR, Uriel, N, Naka, Y, Cleveland, JCJr., Yuzefpolskaya, M, Salerno, CT, et al.. A fully magnetically levitated left ventricular assist device – final report. N Engl J Med 2019;380:1618–27. https://doi.org/10.1056/nejmoa1900486.Search in Google Scholar

12. Lier, H, Vorweg, M, Hanke, A, Görlinger, K. Thromboelastometry guided therapy of severe bleeding. Essener Runde algorithm. Hämostaseologie 2013;33:51–61. https://doi.org/10.5482/HAMO-12-05-0011.Search in Google Scholar PubMed

13. Görlinger, K, Dirkmann, D, Hanke, AA. Rotational thromboelastometry (ROTEM®). In: Gonzalez, E, Moore, HB, Moore, EE, editors. Trauma induced coagulopathy. Cham: Springer International Publishing; 2016:267–98 pp.10.1007/978-3-319-28308-1_18Search in Google Scholar

14. Lechner, R, Helm, M, Müller, M, Wille, T, Riesner, HJ, Friemert, B. In vitro study of species-specific coagulation differences in animals and humans using rotational thromboelastometry (ROTEM). J Roy Army Med Corps 2019;165:356–9. https://doi.org/10.1136/jramc-2018-001092.Search in Google Scholar PubMed

15. Linde, T, Clauser, J, Meuris, B, Steinseifer, U. Assessing the thrombogenic potential of heart valve prostheses: an approach for a standardized in vitro method. Cardiovasc Eng Technol 2019;10:216–24. https://doi.org/10.1007/s13239-019-00408-3.Search in Google Scholar PubMed

16. Brockhaus, MK, Behbahani, MJ, Muris, F, Jansen, SV, Schmitz-Rode, T, Steinseifer, U, et al.. In vitro thrombogenicity testing of pulsatile mechanical circulatory support systems: design and proof-of-concept. Artif Organs 2021;45:1513–21. https://doi.org/10.1111/aor.14046.Search in Google Scholar PubMed

17. Vagdatli, E, Gounari, E, Lazaridou, E, Katsibourlia, E, Tsikopoulou, F, Labrianou, I. Platelet distribution width: a simple, practical and specific marker of activation of coagulation. Hippokratia 2010;14:28–32.Search in Google Scholar

18. Lier, H, Maegele, M. ER-Pocket-Faltkarte – Algorithmus AWMF-LL-Polytrauma. Homepage: Essener Runde. Available from: http://www.essener-runde.de/images/Faltkarte_ER-Algorithmus_AWMF-LL-Polytrauma_26-09-2018.pdf [Accessed 12 Aug 2021].Search in Google Scholar

19. Koster, A, Despotis, G, Gruendel, M, Fischer, T, Praus, M, Kuppe, H, et al.. The plasma supplemented modified activated clotting time for monitoring of heparinization during cardiopulmonary bypass: a pilot investigation. Anesth Analg 2002;95:26–30, table of contents. https://doi.org/10.1097/00000539-200207000-00004.Search in Google Scholar PubMed

20. Kandrotas, RJ. Heparin pharmacokinetics and pharmacodynamics. Clin Pharmacokinet 1992;22:359–74. https://doi.org/10.2165/00003088-199222050-00003.Search in Google Scholar PubMed

21. Jandik, KA, Kruep, D, Cartier, M, Linhardt, RJ. Accelerated stability studies of heparin. J Pharm Sci 1996;85:45–51. https://doi.org/10.1021/js9502736.Search in Google Scholar PubMed

22. Henry, TD, Satran, D, Knox, LL, Iacarella, CL, Laxson, DD, Antman, EM. Are activated clotting times helpful in the management of anticoagulation with subcutaneous low-molecular-weight heparin? Am Heart J 2001;142:590–3. https://doi.org/10.1067/mhj.2001.117317.Search in Google Scholar PubMed

23. Thamsen, B, Blümel, B, Schaller, J, Paschereit, CO, Affeld, K, Goubergrits, L, et al.. Numerical analysis of blood damage potential of the HeartMate II and HeartWare HVAD rotary blood pumps. Artif Organs 2015;39:651–9. https://doi.org/10.1111/aor.12542.Search in Google Scholar PubMed

24. Girdhar, G, Bluestein, D. Biological effects of dynamic shear stress in cardiovascular pathologies and devices. Expert Rev Med Dev 2008;5:167–81. https://doi.org/10.1586/17434440.5.2.167.Search in Google Scholar PubMed PubMed Central

25. Woelke, E, Klein, M, Mager, I, Schmitz-Rode, T, Steinseifer, U, Arens, J, et al.. Miniaturized test loop for the assessment of blood damage by continuous-flow left-ventricular assist devices. Ann Biomed Eng 2020;48:768–79. https://doi.org/10.1007/s10439-019-02404-z.Search in Google Scholar PubMed

26. Bluestein, D, Einav, S, Slepian, MJ. Device thrombogenicity emulation: a novel methodology for optimizing the thromboresistance of cardiovascular devices, J Biomech 2013;46:338–44. https://doi.org/10.1016/j.jbiomech.2012.11.033.Search in Google Scholar PubMed PubMed Central

27. Lehle, K, Philipp, A, Zeman, F, Lunz, D, Lubnow, M, Wendel, H-P, et al.. Technical-induced hemolysis in patients with respiratory failure supported with veno-venous ECMO – prevalence and risk factors. PLoS One 2015;10:e0143527. https://doi.org/10.1371/journal.pone.0143527.Search in Google Scholar PubMed PubMed Central

28. Tiedge, S, Optenhöfel, J. Erste Einsätze einer neuen Diagonalpumpe in extrakorporalen Unterstützungssystemen bei Kindern und Säuglingen. Kardiotechnik 2011;20:72–6.Search in Google Scholar

Received: 2022-02-17
Accepted: 2022-08-02
Published Online: 2022-08-31
Published in Print: 2022-12-16

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 16.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/bmt-2022-0078/html
Scroll to top button